Patient Matching and unique patient identifier reform; Increase and support HIE funding streams including Medicaid programs such as HITECH and SUPPORT Acts; Outreach to CDC regarding American Rescue Plan funding for data infrastructure; Seeking GAO report to study how HIEs have accessed and used federal HITECH Act funds
Reform of privacy regulations such as 42 CFR Part 2 and other health data exchange regulations
Inclusion of HIEs in future infrastructure legislation
Duration: October 1, 2017
to
June 30, 2021
General Issues: Health Issues , Veterans , Disaster Planning/Emergencies , Budget/Appropriations , Insurance , Medicare/Medicaid , Pharmacy
Spending: about $300,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2017: U.S. Senate, House of Representatives, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2021
BUCHANAN INGERSOLL & ROONEY PC terminated an engagement in which they represented Strategic Health Information Exchange Collaborative on July 12, 2021.
Original Filing: 301275168.xml
Lobbying Issues
Patient Matching and unique patient identifier reform; Increase and support HIE funding streams including Medicaid programs such as HITECH and SUPPORT Acts; Outreach to CDC regarding American Rescue Plan funding for data infrastructure; Seeking GAO report to study how HIEs have accessed and used federal HITECH Act funds
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Reform of privacy regulations such as 42 CFR Part 2 and other health data exchange regulations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Inclusion of HIEs in future infrastructure legislation
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies
1st Quarter, 2021
In Q1, BUCHANAN INGERSOLL & ROONEY PC lobbied for Strategic Health Information Exchange Collaborative , earning $20,000. The report was filed on April 19, 2021.
Original Filing: 301256015.xml
Lobbying Issues
Patient Matching and unique patient identifier reform; Increase and support HIE funding streams including Medicaid programs such as HITECH and SUPPORT Acts; Outreach to CDC regarding American Rescue Plan funding for data infrastructure; Seeking GAO report to study how HIEs have accessed and used federal HITECH Act funds
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Reform of privacy regulations such as 42 CFR Part 2 and other health data exchange regulations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Inclusion of HIE support in American Rescue Plan and related bills regarding immunization modernization and data infrastructure; Inclusion of HIEs in future infrastructure legislation
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies
4th Quarter, 2020
In Q4, BUCHANAN INGERSOLL & ROONEY PC lobbied for Strategic Health Information Exchange Collaborative , earning $20,000. The report was filed on Jan. 21, 2021.
Original Filing: 301245838.xml
Lobbying Issues
H.R. 6379; Regulatory response to RFI on health system resilience; Public health surveillance and data infrastructure finding; Data infrastructure and connectivity including demos for CDC, HHS, and ONC; Patient Matching and unique patient identifier reform; Increase and support HIE funding streams including Medicaid programs such as HITECH and SUPPORT Acts; inclusion of enhanced HIE funding and resources in CARES Act and future COVID-19 related packages; GAO Report examining the federal funding of HIEs, the status of health data infrastructure, and the role HIEs have played responding to COVID and other emergencies; Consolidated Appropriations Act, 2021 (Including Coronavirus Stimulus & Relief; H.R. 133; P.L. 116-260)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Reform of privacy regulations found in 42 CFR Part 2
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); Families First Coronvirus Reponse Act (P.L. 116-127); Coronvirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123); H.R. 6379; Response to Senate HELP White Paper on Pandemic Preparedness
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies
3rd Quarter, 2020
In Q3, BUCHANAN INGERSOLL & ROONEY PC lobbied for Strategic Health Information Exchange Collaborative , earning $20,000. The report was filed on Oct. 20, 2020.
Original Filing: 301224182.xml
Lobbying Issues
Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); Families First Coronvirus Reponse Act (P.L. 116-127); Coronvirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123); H.R. 6379; Regulatory response to RFI on health system resilience; Public health surveillance and data infrastructure finding; Data infrastructure and connectivity including demos for CDC, HHS, and ONC; Patient Matching and unique patient identifier reform; Increase and support HIE funding streams including Medicaid programs such as HITECH and SUPPORT Acts; inclusion of enhanced HIE funding and resources in CARES Act and future COVID-19 related packages; FY 2021 Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Reform of privacy regulations found in 42 CFR Part 2
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); Families First Coronvirus Reponse Act (P.L. 116-127); Coronvirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123); H.R. 6379; Response to Senate HELP White Paper on Pandemic Preparedness
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies
2nd Quarter, 2020
In Q2, BUCHANAN INGERSOLL & ROONEY PC lobbied for Strategic Health Information Exchange Collaborative , earning $20,000. The report was filed on July 20, 2020.
Original Filing: 301194702.xml
Lobbying Issues
Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); Families First Coronvirus Reponse Act (P.L. 116-127); Coronvirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123); H.R. 6379; Regulatory response to RFI on health system resilience; Public health surveillance and data infrastructure finding; Data infrastructure and connectivity including demos for CDC, HHS, and ONC; Patient Matching and unique patient identifier reform; Increase and support HIE funding streams including Medicaid programs such as HITECH and SUPPORT Acts; inclusion of enhanced HIE funding and resources in CARES Act and future COVID-19 related packages
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Reform of privacy regulations found in 42 CFR Part 2
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); Families First Coronvirus Reponse Act (P.L. 116-127); Coronvirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123); H.R. 6379; Response to Senate HELP White Paper on Pandemic Preparedness
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies
1st Quarter, 2020
In Q1, BUCHANAN INGERSOLL & ROONEY PC lobbied for Strategic Health Information Exchange Collaborative , earning $20,000. The report was filed on April 20, 2020.
Original Filing: 301179944.xml
Lobbying Issues
Reauthorization of the Pandemic All Hazards Preparedness Act or PAHPA; HHS ONC's proposed Trusted Exchange Framework and Common Agreement to improve interoperability and health information exchange; Reform of privacy regulations found in 42 CFR Part 2; Collaboration on CDC efforts regarding data sharing; Engagement on Cures 2.0 and other interoperability legislative efforts; Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); Families First Coronvirus Reponse Act (P.L. 116-127); Coronvirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123); H.R. 6379
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Reform of privacy regulations found in 42 CFR Part 2
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Reauthorization of the Pandemic All Hazards Preparedness Act or PAHPA (H.R. 269); Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); Families First Coronvirus Reponse Act (P.L. 116-127); Coronvirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123); H.R. 6379
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies
4th Quarter, 2019
In Q4, BUCHANAN INGERSOLL & ROONEY PC lobbied for Strategic Health Information Exchange Collaborative , earning $20,000. The report was filed on Jan. 22, 2020.
Original Filing: 301129594.xml
Lobbying Issues
Reauthorization of the Pandemic All Hazards Preparedness Act or PAHPA; HHS ONC's proposed Trusted Exchange Framework and Common Agreement to improve interoperability and health information exchange; Reform of privacy regulations found in 42 CFR Part 2; Collaboration on CDC efforts regarding data sharing; Engagement on Cures 2.0 and other interoperability legislative efforts
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Reform of privacy regulations found in 42 CFR Part 2
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Reauthorization of the Pandemic All Hazards Preparedness Act or PAHPA (H.R. 269)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies
3rd Quarter, 2019
In Q3, BUCHANAN INGERSOLL & ROONEY PC lobbied for Strategic Health Information Exchange Collaborative , earning $20,000. The report was filed on Oct. 21, 2019.
Original Filing: 301076474.xml
Lobbying Issues
Reauthorization of the Pandemic All Hazards Preparedness Act or PAHPA; HHS ONC's proposed Trusted Exchange Framework and Common Agreement to improve interoperability and health information exchange; Reform of privacy regulations found in 42 CFR Part 2; Collaboration on CDC efforts regarding data sharing; Engagement on Cures 2.0 and other interoperability legislative efforts
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Reform of privacy regulations found in 42 CFR Part 2
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Reauthorization of the Pandemic All Hazards Preparedness Act or PAHPA (H.R. 269)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies
2nd Quarter, 2019
In Q2, BUCHANAN INGERSOLL & ROONEY PC lobbied for Strategic Health Information Exchange Collaborative , earning $20,000. The report was filed on July 22, 2019.
Original Filing: 301055281.xml
Lobbying Issues
Reauthorization of the Pandemic All Hazards Preparedness Act or PAHPA; HHS ONC's proposed Trusted Exchange Framework and Common Agreement to improve interoperability and health information exchange; Reform of privacy regulations found in 42 CFR Part 2; Collaboration on CDC efforts regarding data sharing; Engagement on Cures 2.0 and other interoperability legislative efforts
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Reform of privacy regulations found in 42 CFR Part 2
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Reauthorization of the Pandemic All Hazards Preparedness Act or PAHPA (H.R. 269)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies
1st Quarter, 2019
In Q1, BUCHANAN INGERSOLL & ROONEY PC lobbied for Strategic Health Information Exchange Collaborative , earning $20,000. The report was filed on April 22, 2019.
Original Filing: 301035210.xml
Lobbying Issues
Reauthorization of the Pandemic All Hazards Preparedness Act or PAHPA; HHS ONC's proposed Trusted Exchange Framework and Common Agreement to improve interoperability and health information exchange; Reform of privacy regulations found in 42 CFR Part 2; Collaboration on CDC efforts regarding data sharing
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Reform of privacy regulations found in 42 CFR Part 2
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Reauthorization of the Pandemic All Hazards Preparedness Act or PAHPA (H.R. 269)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies
4th Quarter, 2018
In Q4, BUCHANAN INGERSOLL & ROONEY PC lobbied for Strategic Health Information Exchange Collaborative , earning $20,000. The report was filed on Jan. 22, 2019.
Original Filing: 301014507.xml
Lobbying Issues
Reauthorization of the Pandemic All Hazards Preparedness Act or PAHPA; HHS ONC's proposed Trusted Exchange Framework and Common Agreement to improve interoperability and health information exchange; The Overdose Protection and Patient Safety Act (H.R. 6082); SUPPORT for Patients and Communities Act (H.R. 6); Reform of privacy regulations found in 42 CFR Part 2; Collaboration on CDC efforts regarding data sharing
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Reauthorization of the Pandemic All Hazards Preparedness Act or PAHPA
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Veterans Disaster Planning/Emergencies
3rd Quarter, 2018
In Q3, BUCHANAN INGERSOLL & ROONEY PC lobbied for Strategic Health Information Exchange Collaborative , earning $20,000. The report was filed on Oct. 22, 2018.
Original Filing: 300994614.xml
Lobbying Issues
Reauthorization of the Pandemic All Hazards Preparedness Act or PAHPA; HHS ONC's proposed Trusted Exchange Framework and Common Agreement to improve interoperability and health information exchange; The Overdose Protection and Patient Safety Act (H.R. 6082); SUPPORT for Patients and Communities Act (H.R. 6)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 4242; S 2193 - VA Care in the Community
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Reauthorization of the Pandemic All Hazards Preparedness Act or PAHPA
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies
2nd Quarter, 2018
In Q2, BUCHANAN INGERSOLL & ROONEY PC lobbied for Strategic Health Information Exchange Collaborative , earning $20,000. The report was filed on July 20, 2018.
Original Filing: 300978801.xml
Lobbying Issues
HR 4242; S 2193 - VA Care in the Community; Reauthorization of the Pandemic All Hazards Preparedness Act or PAHPA; HHS ONC's proposed Trusted Exchange Framework and Common Agreement to improve interoperability and health information exchange
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 4242; S 2193 - VA Care in the Community; P.L. 115-182, VA Mission Act and free flow of health information
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Reauthorization of the Pandemic All Hazards Preparedness Act or PAHPA
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies
1st Quarter, 2018
In Q1, BUCHANAN INGERSOLL & ROONEY PC lobbied for Strategic Health Information Exchange Collaborative , earning $20,000. The report was filed on April 20, 2018.
Original Filing: 300956294.xml
Lobbying Issues
HR 4242; S 2193 - VA Care in the Community; Reauthorization of the Pandemic All Hazards Preparedness Act or PAHPA
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 4242; S 2193 - VA Care in the Community
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Reauthorization of the Pandemic All Hazards Preparedness Act or PAHPA
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies
4th Quarter, 2017
In Q4, BUCHANAN INGERSOLL & ROONEY PC lobbied for Strategic Health Information Exchange Collaborative , earning $20,000. The report was filed on Jan. 19, 2018.
Original Filing: 300929385.xml
Lobbying Issues
General government relations related to health information exchanges
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Budget/Appropriations Health Issues Insurance Medicare/Medicaid Pharmacy
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate